Candriam Equities L Oncology Impact C/ LU1864481541 /
| NAV13/05/2024 | Chg.+1.1400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 232.5900USD | +0.49% | paying dividend | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | 6.11 | 2.59 | -3.71 | -2.64 | 8.63 | 0.22 | -0.35 | -3.24 | 5.02 | 7.89 | 4.95 | +30.34% |
| 2020 | -1.52 | -5.41 | -3.15 | 12.05 | 8.47 | 1.34 | 4.36 | 2.08 | 3.44 | -2.27 | 5.74 | 3.79 | +31.33% |
| 2021 | 0.48 | -4.26 | -0.16 | 2.26 | 0.10 | 3.44 | -1.04 | 5.49 | -3.84 | 3.30 | -6.44 | 3.90 | +2.49% |
| 2022 | -10.55 | -1.82 | 4.57 | -5.92 | -1.41 | -0.04 | 4.29 | -3.22 | -4.78 | 6.96 | 5.99 | -3.52 | -10.50% |
| 2023 | 2.07 | -3.95 | 1.30 | 2.76 | -2.64 | 0.00 | 0.81 | -2.09 | -5.31 | -6.44 | 9.13 | 5.65 | +0.17% |
| 2024 | 1.29 | 4.06 | 1.42 | -3.47 | 3.32 | - | - | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.91% | 11.30% | 11.78% | 14.69% | 17.28% |
| Sharpe ratio | 1.43 | 3.47 | -0.03 | -0.24 | 0.36 |
| Best month | +5.65% | +9.13% | +9.13% | +9.13% | +12.05% |
| Worst month | -3.47% | -3.47% | -6.44% | -10.55% | -10.55% |
| Maximum loss | -6.87% | -6.87% | -16.38% | -26.56% | -26.56% |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,363.1101 | +4.81% | +4.82% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,525.0801 | +4.95% | +5.21% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.7900 | +1.35% | -5.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,235.8101 | +4.04% | +16.44% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,585.9800 | +4.48% | +3.81% | |
| Candriam Equities L Oncology Imp... | reinvestment | 243.1000 | +4.10% | +13.34% | |
| Candriam Equities L Oncology Imp... | paying dividend | 232.5900 | +3.50% | +0.94% | |
| Candriam Equities L Oncology Imp... | paying dividend | 188.3200 | +4.38% | +3.51% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,519.0000 | +0.82% | +1.33% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.1800 | +3.93% | +16.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,081.8301 | +2.30% | -3.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 257.5500 | +4.98% | +16.25% | |
| Candriam Equities L Oncology Imp... | reinvestment | 204.3000 | +0.94% | -7.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 282.3800 | +4.37% | +3.50% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.2100 | +2.19% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,844.0699 | +4.38% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,838.8101 | +4.48% | +3.81% | |
| Candriam Equities L Oncology Imp... | reinvestment | 156.3100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 270.2400 | +3.50% | +0.92% |
Performance
| YTD | +6.61% | ||
|---|---|---|---|
| 6 Months | +19.41% | ||
| 1 Year | +3.50% | ||
| 3 Years | +0.94% | ||
| 5 Years | +60.86% | ||
| 10 Years | - | ||
| Since start | +67.68% | ||
| Year | |||
| 2023 | +0.17% | ||
| 2022 | -10.50% | ||
| 2021 | +2.49% | ||
| 2020 | +31.33% | ||
| 2019 | +30.34% | ||
Dividends
| 29/04/2024 | 4.55 USD |
| 28/04/2023 | 3.39 USD |
| 28/04/2022 | 4.28 USD |
| 28/04/2021 | 4.15 USD |
| 24/04/2020 | 1.50 USD |
